Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Joseph S. Zakrzewski | Director | 2024-01-18 | 100,000 | $19.11 | $1.91MSell |
Adjuvant Global Health Technology Fund LP | 10% Owner | 2024-01-16 | 15,907 | $19.65 | $312.57kSell |
Kabeer Aziz | Director | 2024-01-16 | 15,907 | $19.65 | $312.57kSell |
Kabeer Aziz | Director | 2024-01-16 | 84,093 | $19.65 | $1.65MSell |
Adjuvant Global Health Technology Fund LP | 10% Owner | 2024-01-16 | 84,093 | $19.65 | $1.65MSell |
Robin Shane Readnour | Director | 2024-01-12 | 706 | $21.92 | $15.48kSell |
Robin Shane Readnour | Director | 2024-01-12 | 719 | $21.91 | $15.75kSell |
Robin Shane Readnour | Director | 2024-01-10 | 1,800 | $21.92 | $39.46kSell |
Robin Shane Readnour | Director | 2024-01-10 | 1,869 | $21.93 | $40.99kSell |
Kevin Michael Krause | Chief Strategy Officer | 2024-01-09 | 5,000 | $6.60 | $33.00kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Ra Capital Management LP | 18.67% | 5,551,295 | $17.88M | Institution |
Adjuvant Global Health Technology Fund LP | 16.79% | 4,994,638 | $16.08M | Insider |
Kabeer Aziz | 16.30% | 4,847,000 | $15.61M | Insider |
Ra Capital Management LP | 14.09% | 4,189,129 | $13.49M | Insider |
Tcg Crossover Management LLC | 9.00% | 2,678,209 | $8.62M | Institution |
Bvf Inc | 5.26% | 1,563,963 | $5.04M | Institution |
Citadel Advisors LLC | 5.23% | 1,556,842 | $5.01M | Institution |
Eric Easom | 5.02% | 1,492,301 | $4.81M | Insider |
Frazier Life Sciences Management LP | 4.67% | 1,388,889 | $4.47M | Institution |
Janus Henderson Group PLC | 4.30% | 1,279,975 | $4.12M | Institution |